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Abstract
The zinc finger transcription factor, Ikaros, is a cen-
tral regulator of hematopoiesis. It is required for the 
development of the earliest B cell progenitors and at 
later stages for VDJ recombination and B cell receptor 
expression. Mature B cells rely on Ikaros to set the ac-
tivation threshold for various stimuli, and to choose the 
correct antibody isotype during class switch recombina-
tion. Thus, Ikaros contributes to nearly every level of B 
cell differentiation and function.
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INTRODUCTION
The Ikaros (Ikzf1) zinc finger transcription factor is a 
critical regulator of  hematopoiesis. Originally identified 
as a protein binding regulatory regions of  the lymphocyte 
specific genes dntt (terminal deoxynucleotidyl transfer-
ase)[1] and cd3d[2], Ikaros was soon shown to be required 
for fetal T cell development[3], as well as important steps 
in adult thymic development, such as the pre-T cell 
receptor (TCR) checkpoint and CD4 vs CD8 T cell dif-
ferentiation[4-6]. Far from being T cell specific, Ikaros is 
expressed in virtually all hematopoietic cells in mice[7,8] 
and humans[9-13], and even in the murine neuro-endocrine 
system[14]. In mice, Ikaros has been shown to be crucial 
for hematopoietic stem cell function and renewal, and 
promotes the differentiation of  conventional and plas-
macytoid dendritic cells, natural killer cells, neutrophils 
and erythrocytes[15-21]. Furthermore, Ikaros is a critical 
tumor suppressor because mice bearing mutations in the 
Ikzf1 gene develop T lymphomas with near complete 
penetrance[22-24], and Ikzf1 mutations are found in mul-
tiple types of  human B and T cell lymphomas and leu-
kemias[25-27]. In addition to these key roles in T cells and 
non-lymphoid lineages, Ikaros is a critical regulator of  B 
cell lymphopoiesis and function, and this is discussed in 
detail below. Importantly, unless otherwise stated, experi-
ments referred to in this review were performed in the 
murine system. 
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MECHANISMS OF IKAROS-MEDIATED 
TRANSCRIPTIONAL REGULATION
Ikaros acts as both a transcriptional activator and repres-
sor, depending in large part on the co-factors with which 
it interacts (Table 1). Mechanisms of  Ikaros-mediated 
repression fit into three broad categories: chromatin 
modification, co-repressor recruitment, and competition. 
First, Ikaros colocalizes with pericentromeric heterochro-
matin in lymphocytes[28], and interacts with components 
of  histone deacetylase (HDAC) complexes, including 
Sin3A and Sin3B (Sin3 complex), the chromatin remodel-
ing Mi-2b ATPase (NuRD complex), and HDAC-1 and 
HDAC2 (both Sin3 and NuRD complexes)[29-32]. Thus, 
Ikaros could contribute to transcriptional repression by 
recruiting genes to heterochromatin[33], and/or by recruit-
ing chromatin-modifying complexes to specific genes 
to enforce repressive chromatin. Second, in vitro assays 
have shown that Ikaros can recruit the C terminal bind-
ing protein (CtBP) and CtBP interacting protein (CtIP) 
co-repressors, which may in turn repress transcription 
by interacting directly with the basal transcriptional ma-
chinery (TATA binding protein and transcription factor 
IIB)[32,34,35]. Finally, Ikaros competes with positive factors 
to repress transcription of  genes such Igll1 [Lambda5; 
competes with early B cell factor (EBF)][36], dntt (terminal 
deoxynucleotidyl transferase; competes with Ets)[37], and 
Hes1 (competes with the RBP-Jk/Notch complex)[38]. 
Ikaros may also function as a transcriptional activator. 
Ikaros can activate transcription of  reporter plasmids[39], 
cd8a transcription in developing T cells[40], and adult glo-
bin genes in developing erythrocytes[21]. Interestingly, the 
histone acetyltransferase that contains the SWI/SNF 
chromatin remodeling complex interacts with Ikaros in 
both T cells[31] and erythrocyte precursors[41] and is as-
sociated with transcriptional activation[42]. Furthermore, 
Ikaros also interacts with the positive transcriptional 
elongation factor complex in yolk sac erythroid cells, re-
cruiting it during the induction of  globin genes[43]. Thus, 
Ikaros may activate the transcription of  certain target 
genes, possibly by recruiting SWI/SNF, or promoting 
transcriptional elongation. 
Post-translational modifications of  Ikaros itself  pro-
vide an additional layer of  complexity to Ikaros-mediated 
transcriptional regulation. Ikaros can be phosphorylated 
and dephosphorylated at multiple residues, by casein 
kinase 2 and protein phosphatase 1, respectively[30,44-46]. 
Phosphorylation of  Ikaros in turn inhibits its DNA bind-
ing, ability to block the cell cycle and repress genes such 
as tdt, and recruitment to peri-centromeric heterochro-
matin[44-46]. In addition to phosphorylation, SUMOylation 
at two separate residues (K58 and K240) antagonizes 
interactions between Ikaros and Sin3A, Sin3B, Mi-2b and 
CtBP, and relieves Ikaros mediated repression of  reporter 
plasmids[47]. Thus, Ikaros can repress or activate transcrip-
tion through a variety of  mechanisms depending on post-
translational modifications, cell type, protein partners and 
target gene. 
IKAROS IN B CELL DEVELOPMENT
B cell development in the bone marrow takes place in 
sequential steps that are characterized by gene expression 
programs, and developmental checkpoints centered on 
antigen receptor rearrangement (Figure 1A, Table 2)[48,49]. 
To start, hematopoietic stem cells become progressively 
more restricted to the lymphoid lineage, differentiating 
into lymphoid primed multi-potent progenitors (LMPPs) 
and then common lymphoid progenitors (CLPs)[48]. The 
transcription factor E2A and interleukin-7 receptor (IL-
7R) signaling in CLPs induce the expression of  the B 
lineage specifying transcription factor, EBF1[50-52], and 
together with Flt3 signaling, differentiation into the earli-
est committed B cell developmental stage, the pre-pro B 
cell[53]. EBF1 allows further progression to the pro-B stage 
and induces the expression of  B lineage genes. Crucially, 
one of  these genes is Pax5[54,55], which is required for fur-
ther development[56] and locks in the B lineage by repress-
ing other cell fates[57,58]. At the pro-B stage, cells undergo 
immunoglobulin heavy chain (Igh) rearrangements, and 
successfully rearranged heavy chains pair with the sur-
rogate light chain proteins Lambda5 and VpreB1/2 to 
provide a maturation signal[59,60]. This pre-B cell receptor 
(BCR) signaling, combined with IL-7R signals, induces 
differentiation into pre-B cells, several rounds of  division, 
and rearrangement of  the Ig light chain[61-63]. Those cells 
that a express functional BCR, consisting of  Ig heavy and 
light chains, suppress further rearrangements (allelic exclu-
sion) and migrate to the spleen to undergo final matura-
tion steps.
Control of B lineage specification and commitment by 
Ikaros
Ikaros plays crucial roles in B lineage specification and 
commitment. Ik-/- mice lack pre-pro-B cells and exhibit 
a complete block in B lymphopoiesis[64]. Similarly, there 
is a striking reduction in pre-pro-B cells in mice bearing 
a hypomorphic mutation in Ikzf1 (IkL/L), which results 
in Ikaros expression at about 10% of  normal levels[65]. 
Together, these data indicate that Ikaros is crucial for B 
lineage specification. This was originally thought to be 
due to a role for Ikaros in promoting Flt3 and/or IL-7R 
expression on early hematopoietic progenitors because: 
(1) Flt3 and IL-7R signaling are required for pre-pro-B 
cell development[53]; (2) Ik-/- LSK (Lin-Sca1+c-kit+) cells 
lack Flt3 mRNA expression[16]; and (3) Ik-/- LMPPs ex-
press reduced levels of  Il7r mRNA[66]. Retroviral expres-
sion of  IL-7R or Flt3 independently in Ik-/- LSK cells 
however, does not rescue B cell development, indicating 
that (1) it is the reduced expression of  both receptors 
together (not either one individually) which blocks Ik-/- B 
lymphopoiesis, and/or (2) that Ikaros has other impor-
tant functions in B lineage specification[67]. In support of  
the latter view, retroviral expression of  EBF in Ik-/- LSK 
cells does rescue pro-B cell development, indicating that 
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Ikaros contributes to B lineage specification by promot-
ing the expression of  EBF[67]. Ikaros likely contributes to 
EBF expression in part by activating IL-7R expression, as 
IL-7 signals are required for EBF transcription[50,52]. How-
ever, as retroviral expression of  IL-7R could not rescue 
Ik-/- B cell development, there is likely an IL-7 signaling 
independent function for Ikaros in EBF upregulation[67]; 
these functions are not understood at this time. Finally, it 
should be noted that EBF mediated rescue of  Ik-/- pro-B 
cell development was inefficient, indicating that Ikaros is 
likely to play further roles in B lineage specification that 
are independent of  EBF regulation.
Beyond the activation of  B cell specific gene pro-
grams, Ikaros is also critical for B lineage commitment. 
In comparison to Ikaros-sufficient pro-B cell lines, EBF-
induced Ik-/- pro-B cell lines exhibit promiscuous myeloid 
gene expression (e.g. csf1r). More strikingly, like Pax-5-/- 
pro-B lines, Ik-/- pro-B lines can be differentiated into 
macrophages when cultured with macrophage colony-
stimulating factor[67]. Thus, in addition to contributing to 
B lineage specification through the activation of  IL-7R, 
EBf1 and Flt3 expression, Ikaros also locks in the B lin-
eage by shutting off  alternative cell fates.
Ikaros in Ig gene recombination 
Ikaros clearly plays critical roles in B cell development be-
yond specification and commitment. Ikaros hypomorphic 
mice (IkL/L) exhibit a partial block in differentiation be-
tween the pro-B and pre-B stages, indicating that Ikaros 
promotes this transition[65]. Similarly, EBF-induced Ik-/- 
pro-B cell lines do not mature into pre-B cells, further 
demonstrating that Ikaros contributes to developmental 
checkpoints in pro-B cells[67]. Interestingly, early experi-
ments has found that compared with wild type (WT), 
IkL/L pro-B cells express lower levels of  Rag1 and Rag2, 
which mediate VDJ recombination[65], indicating that 
Ikaros may contribute to pre-B development by promot-
ing heavy-chain rearrangements. This was confirmed by 
the observations that EBF-induced Ik-/- pro-B cells lack 
Rag1 and Rag2 expression and Ikaros binds directly to 
their promoters[67]. Thus, it appears that Ikaros controls 
pre-B development by activating Rag gene expression and 
Igh rearrangments. Indeed, Reynaud and colleagues have 
found that DH-JH and especially VH-DJH recombination 
is perturbed or absent in EBF-induced Ik-/- pro-B lines. 
Interestingly, retroviral expression of  Rag1 and 2 in these 
cell lines does not rescue VH-DJH recombination, and 
VH and DJH gene segments are found further from each 
other in the nucleus than in Ikaros-sufficient pro-B cell 
lines[67]. Thus, in addition to promoting Rag gene expres-
sion, Ikaros contributes to Igh locus contraction, a critical 
step required for V-DJ recombination[68], and for pro-B 
to pre-B differentiation.
Beyond the pro-B stage and Igh rearrangement, Ikaros 
is likely to play continued roles in B cell development. 
Ikaros is thought to down-regulate preBCR signaling by 
repressing Igll1 (Lambda5) transcription in preB cells[69,70]. 
Ikaros may also contribute to light-chain rearrangment 
and allelic exclusion. Deletion of  an Ikaros-binding, cis-
acting regulatory element in the Igk locus, abolishes 
monoallelic silencing of  V-J rearrangement, suggesting 
that Ikaros participates in allelic exclusion[71,72]. Ikaros-
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Table 1  Ikaros co-factors
Protein/complex Citation System
NuRD complex (Mi2b, HDACs) [31] Over-expression in murine T cells
[30] Over-expression in a murine DP thymocyte cell line
[41] Endogenous proteins in a murine erythro-leukemia cell line
[32] Over-expression in non-lymphoid cell lines
Sin3 complex (Sin3a/b, HDACs) [34] Over-expression in non-lymphoid cell lines and in murine T cells
[32] Over-expression in non-lymphoid cell lines
CtBP [34] Over-expression in non-lymphoid cell lines and in murine T cells
[32] Over-expression in non-lymphoid cell lines
CtIP [35] Over-expression in non-lymphoid cell lines and in murine T cells
SWI/SNF complex (BRG1, BAFs) [31] Over-expression in murine T cells
[41] Endogenous proteins in a murine erythro-leukemia cell line
pTEFb (cdk9) [43] Endogenous proteins in murine yolk sac erythroid cells
CtBP: C terminal binding protein; CtIP: CtBP interacting protein; pTEFb: Positive transcriptional elongation factor complex; 
HDAC: Histone deacetylase.
Table 2  Critical members of the transcription factor network 
controlling B cell development
Gene Ref. Roles
Ikaros (Ikzf1) [64] Required for earliest B cell progenitors 
[65,67] Required for efficient pro-B to pre-B transition
[67] Required for repression of non-B cell fates
[65,67] Promotes Igh rearrangment and Rag 
expression
E2A (Tcfe2a) [51] Required for earliest B cell progenitors 
[86] Required for EBF1 expression
EBF1 (Ebf1) [87] Required for expression of B lineage genes 
development past pro-B stage
Pax5 (Pax5) [56] Required for differentiation past pro-B stage
[57,58] Required for commitment to B cell lineage (e.g. 
repression of alternative fates)
EBF1: Early B cell factor 1.
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mediated control of  this process has not been rigorously 
tested, however, as the entire silencer (> 4 kb) rather 
than specific Ikaros binding sites, is deleted, and allelic 
exclusion has yet to be studied in Ikaros-deficient B cells. 
Finally, considering that Ikaros activates Rag gene expres-
sion in pro-B cells during Igh recombination, this role 
may well be reprised at the pre-B stage to allow for light-
chain recombination. Taken together, these studies dem-
onstrate that Ikaros is crucial to multiple early steps of  B 
cell development.
IKAROS IN MATURE B CELLS
Mature B cells respond to antigen with co-stimulation 
from T cells, eventually undergoing multiple divisions, 
and producing high-affinity antibodies with various con-
stant domains that provide unique effector functions. 
Ikaros controls both the threshold at which B cells re-
spond, as well as the choice of  antibody isotype they will 
express (Figure 1B). 
Ikaros sets the threshold for B cell activation
Ikaros is a crucial regulator of  B cell activation. Ikaros-
deficient IkL/L B cells exhibit lower activation thresholds 
to stimulation than WT cells (e.g. proliferate to lower 
concentrations of  anti-IgM stimulation)[65]. Similarly, B 
cells from mice bearing a B cell specific transgene en-
coding the dominant negative (DN) Ikaros 7 isoform, 
are hyper-responsive to stimulation by mitogens such as 
lipopolysaccharide[73]. Thus, Ikaros sets B cell activation 
thresholds for antigen and mitogen stimuli. Interestingly, 
Ikaros plays a similar role in setting activation thresholds 
for TCR signals in T cells[5,74]. 
While it is clear that Ikaros regulates B cell responses 
to stimulation, the mechanism remains a mystery. Data 
from T cells have suggested that Ikaros maintains acti-
vation thresholds by integrating the inputs of  multiple 
signaling cascades into a transcriptional response to stimu-
lation[5,74]. The rationale for this is two fold: (1) in com-
parison with WT cells, Ik+/- and Ik+/DN T cells are resistant 
to inhibitors of  signaling pathways that lie downstream 
of  the TCR (MAPK, Ras, PI3K/Akt, LCK/FYN, PKC, 
calcineurin), indicating that no one pathway is respon-
sible for increased proliferation; and (2) Ikaros, colocal-
izes with heterochromatin and replication foci, and thus 
its loss might result in widespread gene deregulation[5,74]. 
This latter point may be especially relevant in cycling cells, 
which must synthesize their DNA and re-establish hetero-
chromatin with each cycle. To date however, it is unclear 
if  Ikaros deficiency grossly changes the transcriptional 
response to BCR, TCR or mitogen stimulation in lympho-
cytes, and thus, this model lacks strong experimental sup-
port. 
There are other intriguing possibilities to explain 
how Ikaros controls B cell activation thresholds. First, 
retroviral Ikaros expression in Ik-/- T lymphoma cell lines 
upregulates the cell cycle inhibitor p27kip and blocks cell 
cycle progression[75]. Thus Ikaros might set activation 
135 June 26, 2011|Volume 2|Issue 6|WJBC|www.wjgnet.com
IgH, VpreB,
Checkpoint
Ikaros EBF
BCR
Checkpoint
PreBCRIL-7, Flt3L
IL-7R
Flt3
CLP Pre-pro-B
lambda5
Ikaros
Igh [V-(D-J)]
recombination
Igl (V-J)
recombination
Ikaros
Pre-BPro-B Immature B
IgH, 
IgL
?
B
T
Ikaros
Activation
Antigen
Proliferation Class switch recombination
IgM
IgG1
IgG3
IgE
IgA
IgG1 IgG2b
Ikaros
Figure 1  Ikaros controls multiple levels of B cell lymphopoiesis and function. A: Ikaros plays a crucial role in the specification of the B cell lineage by promoting 
the expression of the IL-7R and Flt3 receptors in common lymphoid progenitors (CLPs) and of the EBF transcription factor in pre-pro-B cells. Later, Ikaros regulates 
Igh recombination by activating Rag gene expression and contracting the Igh locus. After the preBCR check point, Ikaros also downregulates the expression of the 
preBCR component, Lambda5. During light-chain rearrangment, it is thought that Ikaros regulates allelic exclusion; B: In the periphery, Ikaros sets the B cell activation 
threshold to antigen and T cell co-stimulation, and inhibits hyper-proliferation of activated B cells. Finally, during class switch recombination, Ikaros controls isotype 
choice by inhibiting switching to IgG2b and IgG2a and promoting switching to all other isotypes.
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thresholds in B cells by maintaining the expression of  
specific cell cycle inhibitors. Another intriguing possibility 
focuses on the Notch pathway. Ikaros represses Notch 
target genes in T cells[23,38] and Notch activity can syn-
ergize with BCR and CD40 signaling to enhance B cell 
activation[76]. Thus, Ikaros could control BCR-induced 
activation by suppressing Notch pathway activity. Finally, 
it should be noted that while Ca++ mobilization is similar 
between WT and IkL/L B cells after stimulation, the acti-
vation of  other signaling pathways has not been exam-
ined[65]. Furthermore, these comparisons have not been 
rigorously made in T cells. Interestingly, Ikaros appears to 
regulate BCR signaling positively in chicken DT40 cells 
by directly suppressing SHIP phosphatase expression[77,78]. 
While the hypo-responsive phenotype of  Ik-/- DT40 cells 
contrasts with the hyper-responsive phenotype of  Ikaros-
deficient murine B and T cells, work in Ik-/- DT40 cells 
clearly demonstrates that Ikaros can control the sensitiv-
ity of  signaling pathways downstream of  antigen recep-
tors. Thus, it is possible that Ikaros deficiency controls 
lymphocyte activation thresholds by regulating cell cycle 
inhibitors, Notch signals, or BCR, TCR or Toll-like recep-
tor signaling pathways.
It is important to note that the abnormal activation 
threshold in Ikaros-deficient B cells may have real conse-
quences for tolerance. Mutations that compromise B cell 
activation thresholds often lead to autoantibody produc-
tion[79,80]. In keeping with this, mice with B cells express-
ing DN Ikaros express higher levels of  auto antibodies 
than do WT mice[73]. Similarly, Ikaros hypomorphic IkL/L 
mice express auto antibodies (Sellars M, Kastner P and 
Chan S unpublished data). While this suggests a pos-
sible role for Ikaros in the induction of  B cell tolerance, 
it is unclear from current studies if  this would be B cell 
intrinsic role for Ikaros and not one of  its related family 
members. DN Ikaros isoforms retain the ability to inter-
act with and inhibit other Ikaros family members, includ-
ing Aiolos, which also regulates B cell activation thresh-
olds[81]. Thus elevated auto-antibodies in mice expressing 
a B cell restricted DN Ikaros transgene[73], could be due 
in part to Aiolos inhibition. Furthermore, IkL/L T cells 
are hyper-responsive[23], and thus auto-antibodies in these 
mice could be the result of  defective T cell tolerance. 
Further studies with conditional knockouts of  Ikaros will 
be necessary to understand its fully role in B cell toler-
ance.
Ikaros regulates isotype selection during 
immunoglobulin class switch recombination
Class switch recombination (CSR) allows the humoral 
immune response to clear pathogens effectively by pair-
ing a single antibody variable region gene with different 
constant region genes (CH) responsible for unique effec-
tor functions[82]. Recombination occurs between induced 
double stranded breaks in repetitive DNA sequences 
called switch (S) regions; which are located upstream of  
each CH gene (except δ). These breaks are initiated by 
activation-induced cytidine deaminase (AID) in a tran-
scription-dependent manner, the mechanism of  which is 
not fully understood[82,83]. Importantly, it is transcription 
across specific S regions in response to antigen, cytokine, 
and co-stimulatory signals that targets those S regions for 
CSR[84]. Despite its importance, the factors controlling S 
region transcription have remained largely unidentified. 
Recent work has demonstrated that Ikaros is a cen-
tral regulator of  S region transcription and thereby of  
isotype selection during CSR. The first clue to this came 
when IkL/L mice were found to exhibit abnormal serum 
antibody titers, characterized by striking > 50% reduc-
tions in IgG3 and IgG1, and > 50% increases in IgG2b 
and IgG2a[65]. In vitro culture assays then revealed that 
Ikaros deficiency results in increased and ectopic CSR 
to IgG2b and IgG2a, and reduced CSR to all other iso-
types[85]. Mechanistically, Ikaros binds directly to the Igh 
locus, including the 3’ enhancer and S region promoters 
and suppresses activating epigenetic marks (e.g. histone 
acetylation), transcription and AID accessibility across 
Sγ2b and Sγ2a. In fact, this transcriptional repression at a 
subset of  S regions allows other S regions to compete for 
AID-induced CSR. Thus, Ikaros is a master regulator of  
isotype specification during CSR, and mediates this func-
tion by modulating transcriptional competition between S 
regions. 
CONCLUSION
Ikaros controls major aspects of  B cell development and 
B cell responses to antigen. It contributes to B lineage 
specification, commitment and maturation (Figure 1A, 
Table 2). Ikaros activates the expression of  IL7R and 
Flt3, signals through which are critical for the develop-
ment of  the earliest B cell progenitors. Ikaros further 
promotes B cell differentiation by inducing EBF1, which 
itself  activates a B cell transcriptional program. Beyond 
specification, Ikaros plays roles similar to Pax5 in repress-
ing alternative (especially myeloid) fates in B cell progeni-
tors. Finally, Ikaros contributes to further maturation by 
activating Rag gene expression and constricting the Igh 
locus to allow for antigen receptor recombination. Clearly 
Ikaros is a critical regulator of  early B cell development. 
 In the periphery, Ikaros controls activation thresholds 
and isotype choice during CSR. Ikaros appears to control 
CSR by directly regulating activating epigenetic marks 
and transcription at constant region gene promoters 
(Figure 1B). Notably however, the mechanism by which 
Ikaros regulates B cell activation remains largely unde-
fined. Does Ikaros shape the transcriptional response to 
stimulation, repress Notch-mediated proliferation signals, 
directly control the expression of  cell cycle regulators, 
and/or modulate B cell receptor signaling itself? Or does 
Ikaros act through some other mechanism to control B 
cell activation? Future research will be needed to resolve 
these questions. 
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